Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, it's pretty easy to find cutting-edge growth stocks wit ...

DUBLIN, Ohio, Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2024 to shareholders of record at the close of business on April 1, 2024. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solut ...

Core Viewpoint - Cardinal Health emphasizes its commitment to Environmental, Social, and Governance (ESG) principles as integral to its business strategy, aiming to create long-term sustainable value for stakeholders [1]. Group 1: Empowering Employees - The company is focused on fostering an inclusive workplace where employees can be their authentic selves and are treated fairly [2]. - Cardinal Health is actively working to reduce mental health stigma and improve access to mental health services for employees, collaborating with public and private sector leaders to address mental health challenges [2]. Group 2: Creating Value for Customers and Communities - Cardinal Health is enhancing supply chain resiliency to ensure customers receive necessary products for quality patient care [3]. - The company is committed to equitable access to quality healthcare, supported by nearly $22 million in cash and product donations from the company and an additional $1 million from employee contributions, along with over 54,600 hours of volunteer service [3]. Group 3: Operating Sustainably and Responsibly - Cardinal Health has reduced its Scope 1 and Scope 2 greenhouse gas (GHG) emissions by 13% from a fiscal 2019 base year, working towards a 50% reduction goal by fiscal 2030 [4]. - The company has established a baseline for its Scope 3 GHG emissions and submitted a science-based target for validation, with further details expected soon [4]. - A life cycle assessment showed that reprocessed compression sleeves have a 40% lower carbon footprint and reduce hospital waste disposal costs by 90% [4]. - Cardinal Health is improving its supplier due diligence program and supply chain mapping to enhance transparency and integrity [4]. Group 4: Reporting Standards - The latest ESG Report was prepared in accordance with the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB), and Task Force on Climate-related Financial Disclosures (TCFD) frameworks [5].

Cardinal Health (CAH) recently announced its acquisition of Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization, for $1.2 billion in cash.This acquisition is likely to create a platform for the company’s expansion across specialty therapeutic areas, along with creating increased clinical and economic value for more than 11,500 specialty providers.Price PerformanceFor the past six months, CAH’s shares have gained 19.3% against the industry’s decline ...

Cardinal Health, Inc. (NYSE:CAH) Q2 2024 Earnings Conference Call February 1, 2024 8:30 AM ET Company Participants Matt Sims - Vice President, Investor Relations Jason Hollar - Chief Executive Officer Aaron Alt - Chief Financial Officer Conference Call Participants Stephanie Davis - Barclays Lisa Gill - JP Morgan Elizabeth Anderson - Evercore ISI Eric Percher - Nephron Research Erin Wright - Morgan Stanley Allen Lutz - Bank of America Kevin Caliendo - UBS George Hill - Deutsche Bank Stephen Baxter - Wells F ...

Cardinal Health, Inc. (CAH) reported second-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.82, which beat the Zacks Consensus Estimate of $1.56 by 16.7%. The bottom line also improved 38% year over year.GAAP EPS in the quarter was $1.43 against the year-ago period’s reported loss of 50 cents per share.Revenue DetailsSales improved 11.6% on a year-over-year basis to $57.45 billion. The top line also outpaced the Zacks Consensus Estimate by 1.1%.Segmental AnalysisPharmaceutical SegmentIn the repo ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and traditional valuation metrics to fin ...

Cardinal Health (CAH) reported $57.45 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 11.6%. EPS of $1.82 for the same period compares to $1.32 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $56.82 billion, representing a surprise of +1.10%. The company delivered an EPS surprise of +16.67%, with the consensus EPS estimate being $1.56.While investors scrutinize revenue and earnings changes year-over-year and how they compare with ...

Shares of Cardinal Health (CAH) have been strong performers lately, with the stock up 4.3% over the past month. The stock hit a new 52-week high of $111.4 in the previous session. Cardinal Health has gained 8.3% since the start of the year compared to the 2.7% move for the Zacks Medical sector and the 1.9% return for the Zacks Medical - Dental Supplies industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn't missed our earnings consensus est ...

Cardinal Health (CAH) came out with quarterly earnings of $1.82 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this prescription drug distributor would post earnings of $1.40 per share when it actually produced earnings of $1.73, delivering a surprise of 23.57%.Over the last four q ...